Literature DB >> 20477619

Influence of FOXP3 on CD4+CD25+ regulatory T cells.

Steven F Ziegler1, Jane H Buckner.   

Abstract

FOXP3, a member of the forkhead family of transcriptional regulatory proteins, is expressed predominantly in CD4(+)CD25(+) regulatory T cells. These cells are vital for maintaining peripheral tolerance. A lack of FOXP3 results in severe lymphoproliferative disease and autoimmunity in both mouse and humans, which is the result of an absence of CD4(+)CD25(+)FOXP3(+) regulatory cells. This review discusses the role that this protein plays in the commitment and function of regulatory T cells and its characteristics of FOXP3. We then discuss how, in humans, the induction of FOXP3 in nonregulatory CD4(+) T cells can result in the generation of regulatory T cells in the periphery. A finding that has implications on both how autoimmunity is regulated in vivo as well an impact on the development of therapeutic interventions for the treatment of autoimmunity.

Entities:  

Year:  2006        PMID: 20477619     DOI: 10.1586/1744666X.2.4.639

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  4 in total

1.  Equine CD4(+) CD25(high) T cells exhibit regulatory activity by close contact and cytokine-dependent mechanisms in vitro.

Authors:  Eman Hamza; Vinzenz Gerber; Falko Steinbach; Eliane Marti
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

2.  Different aspects of CD4 T cells that lead to viral clearance or persistence of HCV infection.

Authors:  Kazushi Sugimoto; Katsuya Shiraki
Journal:  Hepatol Int       Date:  2011-11-30       Impact factor: 6.047

3.  Adenosine promotes Foxp3 expression in Treg cells in sepsis model by activating JNK/AP-1 pathway.

Authors:  Rui Bao; Jiong Hou; Yan Li; Jinjun Bian; Xiaoming Deng; Xiaoyan Zhu; Tao Yang
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

4.  Epigenetic control of Foxp3 by SMYD3 H3K4 histone methyltransferase controls iTreg development and regulates pathogenic T-cell responses during pulmonary viral infection.

Authors:  D E de Almeida Nagata; H-A Ting; K A Cavassani; M A Schaller; S Mukherjee; C Ptaschinski; S L Kunkel; N W Lukacs
Journal:  Mucosal Immunol       Date:  2015-02-11       Impact factor: 7.313

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.